Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention

JK Buitelaar, SA Montgomery… - European …, 2003 - Elsevier
2. 1. Features of ADHD(Biederman et al., 2000). Predicting outcomes is difficult given the
wide variation in developmental differences Attention deficit hyperactivity disorder (ADHD) is …

A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)

A Sharma, J Couture - Annals of Pharmacotherapy, 2014 - journals.sagepub.com
Objective: To review the pathophysiology, etiology, and treatment of attention-deficit
hyperactivity disorder (ADHD). Data Sources and Data Extraction: A literature search was …

Medication treatment for attention deficit hyperactivity disorder

JB Ryan, A Katsiyannis, EM Hughes - Theory Into Practice, 2011 - Taylor & Francis
Attention deficit hyperactivity disorder (ADHD) has become the most commonly diagnosed
psychiatric disorder among school-age children. For more than half a century, physicians …

Non–stimulant medications in the treatment of ADHD

T Banaschewski, V Roessner, RW Dittmann… - European child & …, 2004 - Springer
Background Stimulants are the first–line medication in the psychopharmacological treatment
of attention–deficit hyperactivity disorder (ADHD). However, 10 to 30% of all children and …

Pharmacological intervention research for academic outcomes for students with ADHD

JB Ryan, R Reid, MH Epstein, C Ellis… - Behavioral …, 2005 - journals.sagepub.com
This study reviews the status and trends of pharmacological intervention research focused
on the academic functioning of children and adolescents with attention deficit hyperactivity …

Efficacy, safety, and tolerability of a novel methylphenidate extended-release oral suspension (MEROS) in ADHD

AS Robb, RL Findling, AC Childress… - Journal of Attention …, 2017 - journals.sagepub.com
Objective: To test whether an optimal dose of Quillivant XR (methylphenidate extended-
release oral suspension [MEROS]) would significantly reduce symptoms of ADHD in …

Anxiety, methylphenidate response, and working memory in children with ADHD

AC Bedard, R Tannock - Journal of attention disorders, 2008 - journals.sagepub.com
Objective: To investigate the effects of methylphenidate (MPH) on components of working
memory (WM) in children with ADHD and determine whether MPH produces differential …

Impact of attention-deficit hyperactivity disorder on school performance: what are the effects of medication?

R Baweja, RE Mattison, JG Waxmonsky - Pediatric Drugs, 2015 - Springer
Attention-deficit hyperactivity disorder (ADHD) affects an estimated 5–7% of schoolchildren
worldwide. School functioning and academic achievement are frequently impaired by ADHD …

Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers: is it justified?

JK Ghuman, HS Ghuman - Pediatric Drugs, 2013 - Springer
Pharmacologic intervention for attention-deficit hyperactivity disorder (ADHD) in preschool
children is a controversial issue. Non-pharmacologic interventions (psychosocial and …

Attention‐deficit‐hyperactivity disorder: an update

JA Dopheide, SR Pliszka - Pharmacotherapy: The Journal of …, 2009 - Wiley Online Library
Attention‐deficit‐hyperactivity disorder (ADHD) is a common neuropsychiatric disorder that
impairs social, academic, and occupational functioning in children, adolescents, and adults …